Existing drugs may hinder development of bone metastasis in breast cancer patients
Researchers at Tel Aviv University (TAU) have developed a new therapeutic strategy based on existing medications to inhibit bone metastasis in breast cancer patients. Using both an animal model and tissue samples from patients in Israel and the US, they demonstrated that a combination of drugs already available on the market can hinder bone metastasis… Read More